These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9757039

  • 1. Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine.
    Wolf A, Jackson A, Price T, Trevino A, Caldarola-Pastuszka M, Uphouse L.
    Brain Res; 1998 Sep 07; 804(2):206-11. PubMed ID: 9757039
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of the 5-HT1A agonists, 5-hydroxy- and 5-methoxy-(3-di-n-propylamino)chroman, on female lordosis behavior.
    Uphouse L, Caldarola-Pastuszka M, Moore N.
    Neuropharmacology; 1993 Jul 07; 32(7):641-51. PubMed ID: 8361579
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Uphouse L, Andrade M, Caldarola-Pastuszka M, Maswood S.
    Pharmacol Biochem Behav; 1994 Mar 07; 47(3):467-70. PubMed ID: 8208763
    [Abstract] [Full Text] [Related]

  • 4. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W, Harrison L, Guptarak J, White S, Hiegel C, Uphouse L.
    Brain Res; 2003 Jun 06; 974(1-2):202-11. PubMed ID: 12742638
    [Abstract] [Full Text] [Related]

  • 5. 5-HT1A receptor antagonists and lordosis behavior.
    Uphouse L, Andrade M, Caldarola-Pastuszka M, Jackson A.
    Neuropharmacology; 1996 Apr 06; 35(4):489-95. PubMed ID: 8793912
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
    Selvamani A, Lincoln C, Uphouse L.
    Behav Brain Res; 2007 Apr 16; 179(1):99-106. PubMed ID: 17336403
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
    Trevino A, Wolf A, Jackson A, Price T, Uphouse L.
    Horm Behav; 1999 Jun 16; 35(3):215-23. PubMed ID: 10373334
    [Abstract] [Full Text] [Related]

  • 13. WAY100635 and female rat lordosis behavior.
    Uphouse L, Wolf A.
    Brain Res; 2004 Jul 09; 1013(2):260-3. PubMed ID: 15193537
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective actions of the 5-HT2A/2C receptor agonist, DOI, on 5-HT1A receptor-mediated inhibition of lordosis behavior.
    Maswood S, Andrade M, Caldarola-Pastuszka M, Uphouse L.
    Neuropharmacology; 1996 Apr 09; 35(4):497-501. PubMed ID: 8793913
    [Abstract] [Full Text] [Related]

  • 16. 5,7-DHT facilitated lordosis: effects of 5-HT agonists.
    Aiello-Zaldivar M, Luine V, Frankfurt M.
    Neuroreport; 1992 Jun 09; 3(6):542-4. PubMed ID: 1391765
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Jackson A, Uphouse L.
    Horm Behav; 1996 Jun 09; 30(2):145-52. PubMed ID: 8797023
    [Abstract] [Full Text] [Related]

  • 19. Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists.
    Wolf A, Caldarola-Pastuszka M, Uphouse L.
    Brain Res; 1998 Jan 01; 779(1-2):84-95. PubMed ID: 9473601
    [Abstract] [Full Text] [Related]

  • 20. Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats.
    Hemrick-Luecke SK, Fuller RW.
    Biochem Pharmacol; 1995 Jan 31; 49(3):323-7. PubMed ID: 7857319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.